Aurora-A Kinase: A Potent Oncogene and Target for Cancer Therapy

doi:10.1002/med.21399

Review

. 2016 Nov;36(6):1036-1079.

doi: 10.1002/med.21399. Epub 2016 Jul 13.

Aurora-A Kinase: A Potent Oncogene and Target for Cancer Therapy

Min Yan^{1

2}, Chunli Wang³, Bin He¹, Mengying Yang³, Mengying Tong³, Zijie Long⁴, Bing Liu³, Fei Peng³, Lingzhi Xu³, Yan Zhang¹, Dapeng Liang³, Haixin Lei³, Sen Subrata⁵, Keith W Kelley^{6

7}, Eric W-F Lam⁸, Bilian Jin⁹, Quentin Liu^{10

11

12}

Affiliations

¹ State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-sen University, Guangzhou, China.
² Institute of Human Virology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.
³ Institute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, China.
⁴ Institute of Hematology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
⁵ Department of Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁶ Laboratory of Immunophysiology, Department of Animal Sciences, College of ACES, University of Illinois at Urbana-Champaign, Urbana, IL, USA.
⁷ Department of Pathology, College of Medicine, University of Illinois at Urbana-Champaign, Urbana, IL, USA.
⁸ Department of Surgery and Cancer, Imperial College London, London, UK.
⁹ Institute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, China. jinbilian@dmu.edu.cn.
¹⁰ State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-sen University, Guangzhou, China. liuq9@mail.sysu.edu.cn.
¹¹ Institute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, China. liuq9@mail.sysu.edu.cn.
¹² Institute of Hematology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. liuq9@mail.sysu.edu.cn.

PMID: 27406026
DOI: 10.1002/med.21399

Free article

Review

Aurora-A Kinase: A Potent Oncogene and Target for Cancer Therapy

Min Yan et al. Med Res Rev. 2016 Nov.

Free article

. 2016 Nov;36(6):1036-1079.

doi: 10.1002/med.21399. Epub 2016 Jul 13.

Authors

Affiliations

¹ State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-sen University, Guangzhou, China.
² Institute of Human Virology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.
³ Institute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, China.
⁴ Institute of Hematology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
⁵ Department of Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁶ Laboratory of Immunophysiology, Department of Animal Sciences, College of ACES, University of Illinois at Urbana-Champaign, Urbana, IL, USA.
⁷ Department of Pathology, College of Medicine, University of Illinois at Urbana-Champaign, Urbana, IL, USA.
⁸ Department of Surgery and Cancer, Imperial College London, London, UK.
⁹ Institute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, China. jinbilian@dmu.edu.cn.
¹⁰ State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-sen University, Guangzhou, China. liuq9@mail.sysu.edu.cn.
¹¹ Institute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, China. liuq9@mail.sysu.edu.cn.
¹² Institute of Hematology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. liuq9@mail.sysu.edu.cn.

PMID: 27406026
DOI: 10.1002/med.21399

Abstract

The Aurora kinase family is comprised of three serine/threonine kinases, Aurora-A, Aurora-B, and Aurora-C. Among these, Aurora-A and Aurora-B play central roles in mitosis, whereas Aurora-C executes unique roles in meiosis. Overexpression or gene amplification of Aurora kinases has been reported in a broad range of human malignancies, pointing to their role as potent oncogenes in tumorigenesis. Aurora kinases therefore represent promising targets for anticancer therapeutics. A number of Aurora kinase inhibitors (AKIs) have been generated; some of which are currently undergoing clinical evaluation. Recent studies have unveiled novel unexpected functions of Aurora kinases during cancer development and the mechanisms underlying the anticancer actions of AKIs. In this review, we discuss the most recent advances in Aurora-A kinase research and targeted cancer therapy, focusing on the oncogenic roles and signaling pathways of Aurora-A kinases in promoting tumorigenesis, the recent preclinical and clinical AKI data, and potential alternative routes for Aurora-A kinase inhibition.

Keywords: Aurora kinase inhibitors (AKIs); Aurora-A; mitosis; targeted cancer therapy; tumorigenesis.

PubMed Disclaimer

Cited by

Targeting the Warburg effect: A revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer.
Liao M, Yao D, Wu L, Luo C, Wang Z, Zhang J, Liu B. Liao M, et al. Acta Pharm Sin B. 2024 Mar;14(3):953-1008. doi: 10.1016/j.apsb.2023.12.003. Epub 2023 Dec 16. Acta Pharm Sin B. 2024. PMID: 38487001 Free PMC article. Review.
Ligand-based pharmacophore modeling and machine learning for the discovery of potent aurora A kinase inhibitory leads of novel chemotypes.
Banat R, Daoud S, Taha MO. Banat R, et al. Mol Divers. 2024 Mar 6. doi: 10.1007/s11030-024-10814-y. Online ahead of print. Mol Divers. 2024. PMID: 38446372
AURKA inhibition induces Ewing's sarcoma apoptosis and ferroptosis through NPM1/YAP1 axis.
Chen H, Hu J, Xiong X, Chen H, Lin B, Chen Y, Li Y, Cheng D, Li Z. Chen H, et al. Cell Death Dis. 2024 Jan 29;15(1):99. doi: 10.1038/s41419-024-06485-0. Cell Death Dis. 2024. PMID: 38287009 Free PMC article.
Study of Drug Targets Associated With Oncogenesis and Cancer Cell Survival and the Therapeutic Activity of Engineered Ashwagandha Extract Having Differential Withanolide Constitutions.
Cavaleri F, Chattopadhyay S, Palsule V, Kar PK, Chatterjee R. Cavaleri F, et al. Integr Cancer Ther. 2024 Jan-Dec;23:15347354231223499. doi: 10.1177/15347354231223499. Integr Cancer Ther. 2024. PMID: 38281118 Free PMC article.
Aurora kinase A-mediated phosphorylation triggers structural alteration of Rab1A to enhance ER complexity during mitosis.
Zhang W, Zhang Z, Xiang Y, Gu DD, Chen J, Chen Y, Zhai S, Liu Y, Jiang T, Liu C, He B, Yan M, Wang Z, Xu J, Cao YL, Deng B, Zeng D, Lei J, Zhuo J, Lei X, Long Z, Jin B, Chen T, Li D, Shen Y, Hu J, Gao S, Liu Q. Zhang W, et al. Nat Struct Mol Biol. 2024 Feb;31(2):219-231. doi: 10.1038/s41594-023-01165-7. Epub 2024 Jan 4. Nat Struct Mol Biol. 2024. PMID: 38177680

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

Grants and funding

BBS/B/03785/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom

LinkOut - more resources

Full Text Sources
- Spiral, Imperial College Digital Repository
- Wiley
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Aurora-A Kinase: A Potent Oncogene and Target for Cancer Therapy

Affiliations

Aurora-A Kinase: A Potent Oncogene and Target for Cancer Therapy

Authors

Affiliations

Abstract

Similar articles

Cited by

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Abstract

Similar articles

Cited by

Publication types

MeSH terms

Substances

Related information

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical